European drug maker Novartis will license Google’s “smart...
European drug maker Novartis will license Google’s “smart lens” technology for “all ocular medical uses,” Novartis said in a Tuesday news release (http://bit.ly/1ylO6AR). “Google’s key advances in the miniaturization of electronics complement Novartis’s deep pharmaceuticals and medical device expertise,” Novartis…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
said. “Novartis aims to enhance the ways in which diseases are mapped within the body and ultimately prevented.” The company said it will focus on two areas: diabetic patients and those with presbyopia, the diminishing ability to focus on near objects.